Latest / Morning Medical with Dr. Chow / Hantavirus Insights, Semaglutide for Alcohol Use, and Extreme Therapy Risks

Transcript

Hantavirus Insights, Semaglutide for Alcohol Use, and Extreme Therapy Risks · Morning Medical with Dr. Chow

• 0:00
  Welcome to another episode of "Morning Medical with Doctor Chow." I'm your host, Doctor
• 0:04
  Chi-Ming Chow, here to bring you the latest updates in medical and health news from around
• 0:09
  the globe.
• 0:10
  Today, we're diving into a rather concerning topic: Hantavirus infections and their impact
• 0:16
  on the body.
• 0:20
  Hantavirus is a rare but potentially deadly infection that can catch even the healthiest
• 0:25
  individuals off guard.
• 0:27
  To illustrate just how serious this illness can be, let's talk about Jordan Herbst.
• 0:32
  Jordan was only fourteen when he initially thought he had the flu.
• 0:36
  He experienced typical symptoms like aches and chills.
• 0:40
  However, things took a turn for the worse when he began to struggle with his breathing.
• 0:46
  What started as a case of suspected pneumonia quickly escalated to respiratory failure,
• 0:52
  leading to an emergency airlift to a larger hospital where he was put on a machine to
• 0:57
  support his heart and lungs.
• 1:00
  Jordan's experience with hantavirus was likened to drowning.
• 1:04
  "You’re trying to breathe, and you just can’t get the air in," he said.
• 1:09
  This infection isn't one you hear about every day.
• 1:12
  It's primarily contracted through exposure to rodent droppings, urine, or saliva.
• 1:18
  While in the United States, the strain doesn't spread from person to person, there are
• 1:23
  strains, like the one found in South America, that can spread through prolonged close
• 1:28
  contact.
• 1:30
  Globally, the World Health Organization recently reported a troubling situation
• 1:34
  involving a cruise ship in the Atlantic Ocean, where one confirmed and five suspected cases of
• 1:40
  hantavirus were identified among passengers.
• 1:43
  Tragically, three of these individuals have died.
• 1:47
  Although it's unclear how they contracted the virus, this incident underscores the
• 1:52
  seriousness of hantavirus infections.
• 1:55
  Since tracking began in 1993, there have been 890 documented cases of hantavirus in the
• 2:02
  United States, with most occurring west of the Mississippi River.
• 2:06
  The mortality rate is significant, with about thirty-five percent of cases resulting in
• 2:12
  death.
• 2:13
  The symptoms can vary depending on the virus strain, but the Sin Nombre strain, common in
• 2:18
  the United States, and the Andes strain, found in South America, can lead to hantavirus
• 2:24
  pulmonary syndrome.
• 2:26
  This syndrome typically begins with flu-like symptoms such as fever, chills, muscle pain,
• 2:32
  headaches, and gastrointestinal issues, emerging one to six weeks after exposure.
• 2:38
  Unfortunately, the infection can rapidly escalate, as it did with Jordan, affecting the
• 2:44
  blood vessels and causing fluid to leak into the lungs, making it extremely difficult to
• 2:48
  breathe.
• 2:49
  In severe cases, patients require oxygen and may need an artificial heart-lung machine to
• 2:54
  survive.
• 2:56
  There are no specific antiviral medications for hantavirus, which means treatment focuses on
• 3:02
  supportive care, such as oxygen therapy and heart-lung support to help patients manage the
• 3:08
  infection.
• 3:09
  Without prompt diagnosis and treatment, the infection can be fatal within 24 to 48 hours.
• 3:17
  For those who survive, recovery can be prolonged and challenging.
• 3:22
  Like Jordan, many may find themselves fatigued and struggling to regain their previous levels
• 3:27
  of strength.
• 3:29
  Some survivors never fully recover, facing long-term difficulties with strength and
• 3:34
  cognition.
• 3:36
  Jordan's story is a stark reminder of how quickly a hantavirus infection can turn
• 3:40
  life-threatening.
• 3:42
  After spending six days in a medically induced coma, Jordan's journey to recovery was long and
• 3:48
  arduous.
• 3:49
  Instead of starting his freshman year of high school, he spent the next year and a half
• 3:53
  building his strength back up.
• 3:57
  Today, we have some fascinating findings from a new study that suggests a potential
• 4:01
  game-changer in the treatment of alcohol use disorder.
• 4:05
  This study focused on the drug semaglutide, marketed under the name Wegovy, which has
• 4:11
  traditionally been used to treat obesity.
• 4:14
  However, recent trials have shown it may have significant benefits for individuals struggling
• 4:18
  with heavy drinking.
• 4:20
  In this placebo-controlled randomized trial conducted in Denmark, researchers found that
• 4:26
  adults with both obesity and alcohol use disorder experienced a substantial reduction in
• 4:32
  heavy drinking days when treated with semaglutide.
• 4:36
  Participants received a 2.4 milligram weekly dose of the drug, alongside standard cognitive
• 4:42
  behavioral therapy.
• 4:44
  After twenty-six weeks, those on semaglutide had a 41.1 percentage point reduction in heavy
• 4:50
  drinking days compared to just a 26.4 percentage point drop for those on a placebo.
• 4:57
  But the benefits did not stop there.
• 5:00
  Semaglutide was also associated with decreases in overall alcohol consumption and craving
• 5:05
  scores, as well as improvements in biological markers of liver health.
• 5:10
  This is particularly promising as the treatment options for alcohol use disorder are currently
• 5:15
  limited, with few medications widely used or effective.
• 5:19
  The study’s authors suggest that semaglutide, a GLP-1 receptor agonist, could help close this
• 5:26
  treatment gap.
• 5:28
  To put this into perspective, the effect size estimates from the trial are quite meaningful
• 5:33
  when compared to existing Food and Drug Administration-approved therapies for alcohol
• 5:38
  use disorder.
• 5:40
  Current medications, such as disulfiram, acamprosate, and naltrexone, often offer only
• 5:47
  small to moderate reductions in heavy drinking episodes.
• 5:50
  Thus, a more accessible and effective treatment like semaglutide could indeed be a
• 5:56
  game-changer, as noted by George Koob, director of the National Institute on Alcohol Abuse and
• 6:01
  Alcoholism.
• 6:03
  This trial adds to a growing body of research exploring the potential of GLP-1 receptor
• 6:10
  agonists in treating addiction.
• 6:12
  Previous studies have linked GLP-1 medications to lower risks of various substance use
• 6:19
  disorders, including alcohol, cannabis, and opioid use disorders.
• 6:24
  While earlier trials suggested benefits of semaglutide for alcohol addiction in controlled
• 6:29
  settings, this Danish study is the first to test the drug in a real-world,
• 6:34
  treatment-seeking population.
• 6:37
  The study involved 108 adults with moderate to severe alcohol use disorder and comorbid
• 6:43
  obesity, who were randomized to receive either semaglutide or a placebo.
• 6:48
  All participants were also provided with cognitive behavioral therapy.
• 6:52
  The participants had an average age of fifty-two years, and a significant portion had
• 6:57
  severe alcohol use disorder.
• 7:00
  The results were promising, not only for the primary endpoint of reduced heavy drinking days
• 7:05
  but also for secondary outcomes like reduced total alcohol consumption and improved craving
• 7:10
  scores.
• 7:12
  Despite the encouraging findings, it's important to note that not all participants
• 7:16
  responded to semaglutide, illustrating what researchers call the "non-responder
• 7:21
  phenomenon." Additionally, some adverse events were reported, such as gastrointestinal
• 7:27
  symptoms including nausea and vomiting, which are consistent with the known side effects of
• 7:33
  GLP-1 drugs.
• 7:35
  Overall, these findings lend cautious optimism about the role of semaglutide and similar drugs
• 7:42
  in the treatment of alcohol use disorder.
• 7:45
  Researchers are calling for more confirmatory trials to further explore and validate these
• 7:50
  results, as efficacy signals do not always equate to clinical effectiveness.
• 7:57
  Nonetheless, the potential for a new, more effective treatment option is an exciting
• 8:02
  development in the field of addiction medicine.
• 8:06
  In recent years, red light therapy and cold plunges have gained popularity as viral beauty
• 8:12
  and longevity trends.
• 8:15
  But do they really work?
• 8:17
  Let's explore the truth behind these therapies.
• 8:21
  Red light therapy is often marketed as a treatment for inflammation, muscle recovery,
• 8:26
  weight loss, anti-aging, and collagen production.
• 8:30
  The therapy involves exposure to light-emitting diode light, which is close to infrared light
• 8:36
  but remains visible and is considered safer than sunlight.
• 8:40
  The process allows our body to absorb warmth, aiding in cell production and recovery.
• 8:46
  According to dermatologists, consistent use of red light therapy can promote healing of the
• 8:51
  skin and increase collagen production.
• 8:55
  However, users might need to commit to three or four weeks of usage before noticing any visible
• 9:00
  impact.
• 9:01
  Unlike traditional ultraviolet exposure, red light therapy is deemed much safer, as it does
• 9:07
  not carry the same risks associated with ultraviolet radiation.
• 9:12
  On the other hand, contrast therapy, which combines hot saunas and cold plunges, is said
• 9:18
  to offer benefits for muscle recovery and mental acuity.
• 9:22
  The process involves spending time in a hot sauna followed by a plunge into an ice bath.
• 9:28
  This intense switch in temperatures triggers an immediate stress response in the body,
• 9:32
  requiring one to breathe through the shock.
• 9:36
  Some individuals describe the aftermath of a cold plunge as a rush and a shot of life,
• 9:41
  noting improvements in mental mood and clarity.
• 9:44
  A long-term study from Finland indicated that regular practice of this therapy could decrease
• 9:49
  mortality rates by about forty to fifty percent.
• 9:54
  However, it's crucial to ensure you're in good shape before attempting such extreme
• 9:58
  temperature therapies, as they can pose risks if your heart isn't in optimal condition.
• 10:04
  Ultimately, while red light therapy and cold plunges show promise, especially for muscle
• 10:09
  recovery and inflammation, it's important to seek professional medical advice before diving
• 10:14
  into these extreme temperature therapies.
• 10:18
  As always, ensuring your health and safety is the priority before embracing any new wellness
• 10:24
  trends.
• 10:26
  In our final segment today, we're turning our attention to a cautionary tale about the
• 10:31
  potential dangers of dietary supplements.
• 10:35
  This story involves a 24-year-old woman who took a supplement to relieve constipation and
• 10:40
  ended up in the cardiac intensive care unit.
• 10:43
  She ingested a product marketed as "raiz de tejocote," but what she actually consumed had
• 10:49
  far more sinister effects.
• 10:51
  Upon arriving at the emergency department, the woman was experiencing a range of alarming
• 10:57
  symptoms, including confusion, nausea, vomiting, diarrhea, and whole-body numbness.
• 11:04
  Her blood pressure was critically low, and her heart rate was dangerously slow.
• 11:10
  Laboratory tests revealed high potassium levels and an elevated white blood cell count.
• 11:16
  An electrocardiogram showed troubling signs, including bradycardia and specific changes in
• 11:22
  the ST-T wave patterns.
• 11:24
  It turns out that the supplement she took, believed to be tejocote root, actually
• 11:29
  contained yellow oleander, a toxic plant known for its digoxin-like effects on the heart.
• 11:35
  This plant, found in Mexico and Central America, can cause severe cardiac issues
• 11:40
  similar to those seen with digoxin, a drug used to treat heart conditions but with a very
• 11:46
  narrow safety margin.
• 11:48
  The symptoms she experienced were consistent with digoxin-like toxicity, which can be
• 11:54
  challenging to diagnose.
• 11:56
  Key indicators include bradycardia, scooped ST segments on an electrocardiogram, and
• 12:03
  hyperkalemia, which is an elevated level of potassium in the blood.
• 12:08
  In this case, the medical team administered digoxin-specific antibody infusions, which
• 12:13
  helped to alleviate her symptoms.
• 12:16
  After receiving the treatment, the patient's blood pressure improved, though she remained
• 12:21
  bradycardic.
• 12:23
  Her potassium levels normalized, and follow-up electrocardiograms showed improvements in her
• 12:29
  heart's electrical activity.
• 12:32
  She was admitted to the cardiac intensive care unit for further observation and eventually
• 12:37
  made a full recovery.
• 12:39
  This incident highlights the risks associated with unregulated supplements, particularly
• 12:44
  those marketed for weight loss or other health benefits.
• 12:48
  Despite being sold as tejocote root, the product contained toxic yellow oleander, which
• 12:56
  has been found in multiple similar supplements tested by researchers.
• 13:01
  Consumers should exercise caution and be aware of the potential dangers of mislabeled
• 13:07
  products.
• 13:09
  For healthcare providers, it's crucial to remain vigilant for signs of digoxin-like
• 13:13
  toxicity and to be prepared to treat it with the appropriate antibody fragments.
• 13:19
  As always, regulation and consumer awareness are key to preventing such dangerous outcomes.
• 13:25
  Thank you for joining us on today's episode of "Morning Medical with Doctor Chow." We hope you
• 13:30
  found today's topics both enlightening and informative.
• 13:33
  Stay tuned for more updates on the latest in medical and health news.
• 13:38
  Until next time, take care and stay healthy.